Altria Group (1MO) AI Stock Analysis
Altria Group
(Milan:1MO)
No summary available
Altria Group (1MO) vs. iShares MSCI Italy ETF (EWI)
- Market Cap
- EUR 130.29B
- Dividend Yield
- 5.33%
- Average Volume (3M)
- 254
- Price to Earnings (P/E)
- 16.1
- Beta (1Y)
- -0.02
- Revenue Growth
- -2.51%
- EPS Growth
- -11.82%
- Country
- Italy
- Employees
- 5,900
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
Altria Group Business Overview & Revenue Model
Company Description
Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongsi...
Altria Group Earnings Call Summary
The call was predominantly positive. Altria reported adjusted EPS growth, raised full-year guidance, delivered smokeable-products income and margin growth, expanded Marlboro and total PM USA share, grew on! shipments, increased shareholder returns, and maintained a strong balance sheet. These strengths were partly offset by persistent consumer economic pressure, cigarette and oral-tobacco volume declines, lower oral-segment OCI, competitive nicotine-pouch conditions, and ongoing illicit-market and regulatory challenges in e-vapor.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, Altria now expects adjusted diluted EPS in a range of $5.66 to $5.74, representing a growth rate of 4.5% to 6% from a base of $5.42 in 2025, versus beginning-of-year guidance of 2.5% to 5%; the guidance is inclusive of investments in on! PLUS, including the 12-milligram product and flavor line extensions. Management said expectations for the second half of the year regarding stepping up and the imbalance between quarters have not changed, expects duty drawback benefits to be “pretty balanced across Q3 and Q4,” and did not provide further guidance on the potential duty drawback benefit, noting that the PMI contract manufacturing agreement starts in 2027. The company’s progressive dividend goal remains mid-single-digit annual growth, and its debt-to-EBITDA target remains approximately 2x.
Altria Group Risk Analysis
Altria Group disclosed 23 risk factors in its most recent earnings report. Altria Group reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksAltria Group Peers Comparison
Overall Rating
RLX75Outperform
BTI68Neutral
PM68Neutral
TPB65Neutral
XXII40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | $1.97B | 13.37 | 6.20% | 6.83% | 59.23% | 39.66% | |
| 68Neutral | $132.23B | 15.73 | 13.38% | 5.40% | 4.47% | 117.22% | |
| 68Neutral | $325.43B | 30.48 | -119.68% | 2.88% | 7.91% | 24.06% | |
| 65Neutral | $1.35B | 28.28 | 11.93% | 0.47% | 20.10% | -3.19% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 40Underperform | $1.34M | 0.00 | -20.47% | ― | -27.44% | 99.95% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IT:1MO | Altria | 70.00 | 23.80 | 51.53% | |
| BTI | British American Tobacco | 61.52 | 12.03 | 24.30% | |
| PM | Philip Morris International | 208.79 | 69.13 | 49.50% | |
| XXII | 22nd Century Group | 0.07 | -464.93 | -99.99% | |
| TPB | Turning Point Brands Inc | 67.31 | -25.97 | -27.84% | |
| RLX | Rlx Technology, Inc. | 1.61 | -0.69 | -29.97% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.